NASDAQ · NAKA
Nakamoto Inc.
$6.06-$0.82 (-11.99%)
Nakamoto Inc.’s quoted price sits in the lower half of its reported 52-week range, 84.55% below the high.
Loading market information…
NASDAQ · FVE · USD
Stock price, earnings
Quote as of Jan 28, 2022, 05:00 AM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Five Star Senior Living Inc.’s quoted price sits in the upper half of its reported 52-week range, 1.34% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Five Star Senior Living Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Five Star Senior Living Inc. is a U.S.-based company primarily engaged in managing and operating various types of senior living communities. Its operations are divided into two primary segments: Senior Living, and Rehabilitation and Wellness, reflecting its dual focus on residential care and health services. The company's portfolio of senior residential options includes independent living, assisted living, and continuing care retirement communities (CCRCs), alongside skilled nursing facilities (SNFs) and dedicated active adult communities. Within these settings, FVE provides a range of essential services, such as nursing, healthcare, rehabilitation, and general wellness programs. As of year-end 2020, the company's extensive network spanned 31 states and comprised 268 senior living communities, totaling 29,271 living units. This footprint included 243 primarily independent and assisted living communities, accounting for 28,316 units, as well as 9 skilled nursing facilities (SNFs) with 955 units. Founded in 2001, the company initially operated as Five Star Quality Care, Inc. before rebranding to Five Star Senior Living Inc. in March 2017. Its corporate headquarters are situated in Newton, Massachusetts.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 04:36 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| Q2 2020 | Aug 6, 2020 | $0.10 | $285.08M |
|---|
| Q1 2020 | May 7, 2020 | -$0.55 | $297.45M |
|---|
THE ANALYST VIEW
5 ratings in the current snapshot. Strong buy and strong sell are grouped with buy and sell.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$6.06-$0.82 (-11.99%)
Nakamoto Inc.’s quoted price sits in the lower half of its reported 52-week range, 84.55% below the high.
$2.09-$0.01 (-0.48%)
HilleVax, Inc.’s quoted price sits in the upper half of its reported 52-week range, 3.69% below the high.
$1.88$0.00 (0.0%)
Jounce Therapeutics, Inc.’s quoted price sits in the lower half of its reported 52-week range, 64.99% below the high.
$9.60$0.00 (0.0%)
OptiNose, Inc.’s quoted price sits in the lower half of its reported 52-week range, 52.06% below the high.
$0.10-$0.00 (-0.21%)
Zomedica Corp.’s quoted price sits in the lower half of its reported 52-week range, 50.15% below the high.
$0.35+$0.00 (+0.64%)
Asensus Surgical, Inc.’s quoted price sits in the upper half of its reported 52-week range, 12.87% below the high.
$2.05-$0.05 (-2.38%)
Aadi Bioscience, Inc.’s quoted price sits in the lower half of its reported 52-week range, 46.22% below the high.
$3.39+$0.02 (+0.59%)
Miromatrix Medical Inc.’s quoted price sits in the upper half of its reported 52-week range, 22.07% below the high.
